EFEK PEMBERIAN PROBIOTIK PADA PENDERITA SINDROM METABOLIK; STUDI LITERATUR

Desi Aliefia; Dessy Abdullah; Tri Puspita Prihatinningrum AF; Zukhri Zainun

doi:10.59003/nhj.v4i3.1218

Authors

Desi Aliefia Universitas Baiturrahmah
Dessy Abdullah universitas baiturrahmah
Tri Puspita Prihatinningrum AF Universitas Baiturrahmah
Zukhri Zainun Universitas Baiturrahmah

DOI:

https://doi.org/10.59003/nhj.v4i3.1218

Keywords:

Probiotics, Metabolic Syndrome, Gut Microbiota

Abstract

Developments in probiotic therapy have shown potential to help improve gastrointestinal health. Several studies have been conducted to test the benefits of probiotic use, both in the context of prevention and treatment of various diseases. This article reviews various research results related to the potential use of probiotics in metabolic syndrome. The literature discussing the mechanism of action of probiotics and clinical evidence for their use in conditions such as diabetes, dyslipidemia, and non-alcoholic liver disease are comprehensively reviewed. Although further research is needed, the management of gut microbiota through probiotic administration shows promising prospects as a complementary strategy in the management of metabolic syndrome. The imbalance of gut microbiota, known as dysbiosis, can contribute to the development of various metabolic diseases (Patel, R. and DuPont, L, H., 2015). Recent studies have shown that probiotic administration can improve the composition and function of gut microbiota, thereby helping to prevent or improve symptoms of various diseases associated with metabolic syndrome (Shi, Q. et al., 2022). One of the main mechanisms of probiotics is through their ability to maintain the balance of gut microbiota. By suppressing the growth of pathogenic bacteria and improving the composition of the gut microbiota, probiotics can help overcome problems associated with dysbiosis.

Downloads

Download data is not yet available.

References

Patel, R. and DuPont, L, H. (2015) "New Approaches for Bacteriotherapy: Prebiotics, New- Generation Probiotics, and Synbiotics," Oxford University Press, 60(suppl_2),p. S108- S121. Available at: https://doi.org/10.1093/cid/civ177.

Shi, Q. et al. (2022) "A review on the effect of gut microbiota on metabolic diseases," Springer Science+Business Media, 204(3). Available at: https://doi.org/10.1007/s00203-022- 02802-3.

Sanders, E, M. et al. (2013) "An update on the use and investigation of probiotics in health and disease," BMJ, 62(5),p. 787-796. Available at: https://doi.org/10.1136/gutjnl-2012- 302504.

Fan, Y. and Pedersen, O. (2020) "Gut microbiota in human metabolic health and disease," Nature Portfolio, 19(1),p. 55-71. Available at: https://doi.org/10.1038/s41579-020-0433- 9.

Saad, I, M, S. (2006) "Probióticos e prebióticos: o estado da arte," University of São Paulo, 42(1),p. 1-16. Available at: https://doi.org/10.1590/s1516-93322006000100002.

Tegegne, A, B. and Kebede, B. (2022) "Probiotics, their prophylactic and therapeutic applications in human health development: A review of the literature," Elsevier BV, 8(6),p. e09725-e09725. Available at: https://doi.org/10.1016/j.heliyon.2022.e09725.

Widiyanto, B. et al. (2023) "The Combination of Soursop and Turmeric Leaf Extracts Improves Lipid Profiles in Metabolic Syndrome Model Mice," , 5(1),p. 113-120. Available at: https://doi.org/10.36590/jika.v5i1.413.

Hasani, A. et al. (2021) "The role of Akkermansia muciniphila in obesity, diabetes and atherosclerosis," Microbiology Society, 70(10). Available at: https://doi.org/10.1099/jmm.0.001435.

Freire, L, d, O, M. et al. (2021) "Effects of a Mixed Limosilactobacillus fermentum Formulation with Claimed Probiotic Properties on Cardiometabolic Variables, Biomarkers of Inflammation and Oxidative Stress in Male Rats Fed a High-Fat Diet," Multidisciplinary Digital Publishing Institute, 10(9),p. 2202-2202. Available at: https://doi.org/10.3390/foods10092202.

Sunarti, S., Wahyudin, E. and Kasim, H. (2022) "Efek Asam Askorbat Menurunkan Indeks Aterogenik dan Kadar Gula Darah Tikus (Rattus norvegicus L.) Diabetes Mellitus Induksi Aloksan," , 2(1),p. 1-1. Available at: https://doi.org/10.52365/jecp.v2i1.303.

Hilmi, M. and Prastujati, U, A. (2020) "Optimasi Molase dan Tibicos sebagai Media Fermentasi dalam Memproduksi Nutraceutical Feed Additive Menggunakan Response Surface Methodology (RSM)," , 7(1),p. 1-1. Available at: https://doi.org/10.33772/jitro.v7i1.8441.

Suharyani, I., Chairunisya, N. and Maftuhah, A. (2020) "PROFIL PENGGUNAAN OBAT ANTIDIABETIK ORAL PADA PASIEN RAWAT JALAN PENDERITA DIABETES MELLITUS TIPE II," , 6(1),p. 660-666. Available at: https://doi.org/10.38165/jk.v6i1.145.

Kardina, N, R. et al. (2022) "Edukasi Bahan Makanan Untuk Pencegahan Diabetes Mellitus Pada Ibu – Ibu PKK RT 05 RW 09, Surabaya," Universitas Nahdlatul Ulama Surabaya, 1(1),p. 49-56. Available at: https://doi.org/10.33086/snpm.v1i1.777.

Daeli, E. and Ardiaria, M. (2018) "Pengaruh Pemberian Nasi Beras Merah (Oryza nivara) dan Nasi Beras Hitam (Oryza sativa L.indica) terhadap Perubahan Kadar Gula Darah dan Trigliserida Tikus Wistar (Rattus norvegicus) Diabetes Melitus Tipe 2," , 6(2),p. 42-42. Available at: https://doi.org/10.14710/jnh.6.2.2018.42-56.

Risna, K, Y. et al. (2022) "Aktivitas Antibakteri Bakteri Asam Laktat (BAL) yang Diisolasi dari Saluran Pencernaan Itik Lokal Asal Aceh terhadap Salmonella pullorum dan Escherichia coli," Syiah Kuala University, 22(2),p. 169-174. Available at: https://doi.org/10.17969/agripet.v22i2.24297.